Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefTags

From GxPlex

Jump to: navigation, search

Text

Raw TAG-ID list for this reference (used for glossary queries).

previous 202050100250500next 20
Showing 20 pages using this property.
I
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Sponsor-Investigator +
TAG-00017-Spo-die ++ TAG-00018-Inv-die ++ TAG-00244-Def-ini  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.17 +
TAG-00017-Spo-die ++ TAG-00018-Inv-die ++ TAG-00341-Res-ben  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor-Investigator +
TAG-00017-Spo-die ++ TAG-00018-Inv-die ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud  +
USA 21 CFR Part 812 09-Apr-2025 § 812.3 (o) +
TAG-00017-Spo-die ++ TAG-00018-Inv-die ++ TAG-00244-Def-ini ++ TAG-00202-Inv-Pro ++ TAG-00155-Med-Med  +
USA 21 CFR Part 50 09-Apr-2025 § 50.3 (f) +
TAG-00017-Spo-die ++ TAG-00018-Inv-die ++ TAG-00244-Def-ini ++ TAG-00201-Cli-eSt ++ TAG-00155-Med-Med  +
I
ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 3 +
TAG-00017-Spo-die ++ TAG-00025-Sub-mer ++ TAG-00055-Stu-ngs ++ TAG-00309-Rea-eal  +
ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.1.4 +
TAG-00017-Spo-die ++ TAG-00033-Pro-oto ++ TAG-00128-Dat-rkz ++ TAG-00076-Fea-ung  +
ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.8 +
TAG-00017-Spo-die ++ TAG-00134-Eth-kom ++ TAG-00057-Com-deR ++ TAG-00251-Spo-ezu ++ TAG-00059-Reg-lat  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 24 +
TAG-00017-Spo-die ++ TAG-00244-Def-ini  +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (1) - (5) +
TAG-00017-Spo-die ++ TAG-00244-Def-ini ++ TAG-00008-Cli-ngK  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - sponsor +
TAG-00017-Spo-die ++ TAG-00244-Def-ini ++ TAG-00018-Inv-die  +
I
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Sponsor +
TAG-00017-Spo-die ++ TAG-00244-Def-ini ++ TAG-00341-Res-ben  +
U
USA 21 CFR Part 812 09-Apr-2025 § 812.3 (n) +
TAG-00017-Spo-die ++ TAG-00244-Def-ini ++ TAG-00202-Inv-Pro ++ TAG-00155-Med-Med  +
USA 21 CFR Part 50 09-Apr-2025 § 50.3 (e) +
TAG-00017-Spo-die ++ TAG-00244-Def-ini ++ TAG-00201-Cli-eSt ++ TAG-00155-Med-Med  +
USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor +
TAG-00017-Spo-die ++ TAG-00244-Def-ini ++ TAG-00201-Cli-eSt ++ TAG-00155-Med-Med  +
I
ICH ICH E6 Guideline R3 (2025) III. Annex 1 3 +
TAG-00017-Spo-die ++ TAG-00245-Spo-ten  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 5 +
TAG-00017-Spo-die ++ TAG-00245-Spo-ten  +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (6) - (11) +
TAG-00017-Spo-die ++ TAG-00245-Spo-ten ++ TAG-00040-Sub-Änd ++ TAG-00183-Aut-Ver  +
E
EU EMA/786433/2022 Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 2.5-002 +
TAG-00018-Inv-die ++ TAG-00017-Spo-die ++ TAG-00340-Req-nfo  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 25 +
TAG-00018-Inv-die ++ TAG-00019-Pri-Prü ++ TAG-00244-Def-ini  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefTags&oldid=20452"